Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,693
Total Claims
$927K
Drug Cost
974
Beneficiaries
$952
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+55%
Opioid rate vs peers
63.9% vs 41.3% avg
+139%
Cost per patient vs peers
$952 vs $399 avg
-3%
Brand preference vs peers
3.7% vs 3.8% avg
Opioid Prescribing
63.9%
Opioid Rate
10,033
Opioid Claims
$629K
Opioid Cost
11.8%
Long-Acting Rate
This provider's opioid prescribing rate of 63.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 573 claims · $339K
Generic: 15,120 claims · $589K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 4,385 | $161K |
| Oxycodone Myristate | 160 | $111K |
| Oxycodone Hcl/Acetaminophen | 23 | $101K |
| Hydrocodone/Acetaminophen | 2,382 | $76K |
| Methylnaltrexone Bromide | 19 | $47K |
| Erenumab-Aooe | 51 | $40K |
| Hydrocodone Bitartrate | 62 | $37K |
| Oxycodone Hcl | 1,648 | $36K |
| Buprenorphine | 66 | $32K |
| Fentanyl | 187 | $23K |
| Gabapentin | 1,158 | $22K |
| Linaclotide | 34 | $20K |
| Pregabalin | 692 | $19K |
| Rimegepant Sulfate | 16 | $16K |
| Lidocaine | 89 | $14K |
Prescribing Profile
47
Unique Drugs
12.0
Anomaly Score
Patient Profile
63
Avg Age
66%
Female
1.82
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data